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Independent predictors p value OR 95% CI for OR
High bifurcation angle () <0.0001 1.026 1.014-1.037
Plaque distribution at
the same side of SB
0.0045 1.988 1.237-3.194
MV TIMI ﬂow grade before stenting <0.0001 4.204 2.099-8.420
Pre-procedural diameter stenosis
of bifurcation core (%)
0.0037 1.013 1.004-1.021
Diameter ratio between
MV/SB
<0.0001 5.901 2.933-11.872
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An Angiographic Tool For Risk Prediction Of Side Branch Occlusion In
Coronary Bifurcation Intervention: The RESOLVE Score System
Kefei Dou1, Dong Zhang1, Bo Xu1, Dong Yin1
1Fu Wai Hospital, National Center for Cardiovascular Diseases, China, Beijing,
China
Background: The risk of side branch (SB) occlusion is the most important consid-
eration affecting the selection of an optimal intervention strategy in patients under-
going coronary bifurcation intervention. We aim to establish a scoring system to
evaluate the risk of SB occlusion.
Methods: 1545 consecutive patients undergoing percutaneous coronary inter-
vention for bifurcation lesions (1601 lesions treated with a single stent
technique or main vessel (MV) stenting ﬁrst strategy) were studied. 1200
lesions were used for the construction of the risk model and score system, 401
lesions were used for validating the model. A multivariable risk score was
constructed with incremental weights attributed to each component variable
according to their estimated coefﬁcients. SB occlusion after MV stenting was
deﬁned as any decrease in TIMI ﬂow grade or absence of ﬂow in SB after
MV stenting.
Results: SB occlusion occurred in 118 (7.37%) of 1601 bifurcation lesions. In
multivariable analyses, 6 variables (Table 1) were independently associated with
the risk of SB occlusion (model C-statistic¼0.80 (95% conﬁdence interval [CI]:
0.75 to 0.85) with good calibration). Lesions divided into groups according to the
quartile of RESOLVE score: quartile I was determined as low risk group (score:
0-2); quartiles II and III were combined into an intermediate risk group (score: 3-
9); and quartile IV described high risk group (score: 10). For the 401 lesions
included in the validation cohort, the RESOLVE score had a C-statistic¼0.77
(95% CI: 0.69 to 0.86), with good calibration. SB occlusion rates in the vali-
dation cohort increased signiﬁcantly across different risk groups from 0.0% in
low risk group to 3.8% in intermediate risk group, to 19.8% in high risk group
(p< 0.001).
Conclusions: The RESOLVE score, a novel angiographic risk stratiﬁcation
tool, can help identify patients at risk for SB occlusion during bifurcation
intervention.Predictors Level Point Predictors Level Point
1. Plaque
distribution
4.Pre-procedural
diameter stenosis of
bifurcation core (%)
the
opposite
side of
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0 <50 0
the same
side of
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1 [50,70) 2
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grade before
stenting
70 3
TIMI III 0 5.Bifurcation angle
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How Bifurcation Angle Impact The Fate Of Side Branch After Main Vessel
Stenting: Results From A Large Center
Dong Zhang1, Kefei Dou2, Bo Xu2, Dong Yin2
1Fu Wai Hosptial, Chinese Academy of Medical Sciences & Peking Union Medical
College, Beijing, China, 2Fu Wai Hospital, National Center for Cardiovascular
Diseases, China, Beijing, China
Background: Bifurcation angle (BA) was thought to impact the risk of side branch
(SB) occlusion in coronary bifurcation patients undergoing percutaneous coronary
intervention (PCI). We aim to investigate the effect of BA on SB occlusion after main
vessel (MV) stenting.
Methods: 1171 consecutive patients undergoing PCI for bifurcation lesions (1200
lesions treated with a single stent technique or MV stenting ﬁrst strategy) were
studied. Lesions were divided into low angle and high angle groups using the median
BA (52): 600 lesions in low angle group (52) and 600 lesions in high angle group
(>52). Clinical characteristics, coronary angiography ﬁndings, PCI procedural fac-
tors and quantitative coronary angiographic analysis data were collected. Multivariate
logistic regression analysis was performed to identify independent predictors of SB
occlusion.
Results: SB occlusion occurred in 88 (7.33%) of 1200 bifurcation lesions treated with
one stent technique or MV stenting ﬁrst strategy. Rate of SB occlusion was signiﬁ-
cantly higher in high angle group (67, 10.1%) than low angle group (21, 3.9%) (p<
0.001). Rate of SB occlusion increased signiﬁcantly across different quartiles of BA:
from 3.63% in the ﬁrst quartile of BA, to 4.71% in quartile II, to 8.14% in quartile III
to 12.97% in quartile IV. Multivariable analysis showed that high angle was an in-
dependent predictor of SB occlusion (OR: 1.026, 95% conﬁdence intervals [CI]:
1.014-1.037). 5 other angiographic and procedural factors were also signiﬁcant and
independent predictors of SB branch occlusion (Table 1).
Conclusions: High BA was signiﬁcantly associated with SB occlusion after MV
stenting. Plaque distribution at the same side of SB, MV TIMI ﬂow grade before
stenting, pre-procedural diameter stenosis of bifurcation core, diameter ratio between
MV/SB and diameter stenosis of SB before MV stenting were also independent
predictors of SB occlusion.Diameter stenosis of SB
before MV stenting (%)
<0.0001 1.029 1.018-1.040TCT-181
A Comparative Prospective Analysis of Drug Eluting Stent with Biodegradable
Polymer versus Drug Eluting Stent with Permanent Polymer in Bifurcation
Lesions
Ran Kornowski1, Antonio Serra2, William C. Wijns3, Shigeru Saito4
1Professor of Cardiovascular Medicine, Tel Aviv University, Petach Tikva, Israel,
2Hospital de Sant Pau y Santa Creu, Barcelona, Spain, 3Cardiovascular Center Aalst,
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Background: Clinical outcomes of percutaneous coronary intervention (PCI) in
coronary bifurcation lesions are in general inferior compared to non-bifurcation le-
sions even when treated using drug eluting stents (DES). Our aim was to compare
performance of new Ultimaster DES with bioresorbable polymer with Xience DES
with permanent polymer, in this complex clinical setting.
Methods: In the frame of a large (1123 patients), randomized, intercontinental
CENTURY II study, 194 patients (269 lesions) had at least one bifurcation lesion
treated and randomly assigned to either Ultimaster (95) or Xience DES (99). The study
had 100% on-site monitoring and all events were adjudicated by an independent
clinical event committee.
Results: There were no signiﬁcant differences in demographic characteristics,
approximately 28% of the patients were female, 30% of the patients had diabetes
mellitus, 73% hypertension and 32% had previous MI. Most of the patients were
admitted with stable angina (50%). Patients treated with Ultimaster DES had signif-
icantly more multivessel disease and consequently multivessel treatment: 57.9% vs.
34.7%; (p¼0.04); and 43.4% vs. 20.2% (p¼0.02), respectively. Most of the bifur-
cation lesions were classiﬁed as 1.1.0 (29%), followed by 1.1.1 (22%) and 0.1.1 (10%)
according to “Medina” and most frequent vessel treated was left anterior descending
(48%), with no signiﬁcant differences between the study arms. The number of stent
implanted and the total stent length per patient were signiﬁcantly higher in Ultimasterronary Lesions - Bifurcations B53
Bifurcation type
SB ostium
area(mm2) Jailing pattern
Patient 1-SB 1 OM-LCx 4.81 Proximal and distal
Patient 2-SB 1 LAD-septal 6.22 Crossing
Patient 2-SB 2 LAD-diagonal 1.14 Distal
Patient 2-SB 3 LAD-septal 1.89 Proximal
Patient 3-SB 1 LAD-diagonal 1.58 Distal
Patient 3-SB 2 LAD-septal 1.42 N/A
Patient 4-SB 1 LCx-OM 1.11 Proximal and distal
Patient 5-SB 1 LAD-septal 1.93 Crossing
Patient 5-SB 2 LAD-diagonal 0.46 Distal
Patient 6-SB 1 LCx-OM 1.37 Crossing
Patient 6-SB 2 OM-LCx 2.23 Distal
Patient 8-SB 1 LCx-OM N/Ay Proximal
Patient 8-SB 2 LCx–posterolateral 0.3 Proximal
Patient 8-SB 3 LCx-OM 0.78 Proximal
SATURDAY, SEPTEMBER 13, 2014, 5:00 PM–7:00 PM www.jacctctabstracts2014.comgroup: 1.720.82 vs. 1.56 (p¼0.05) and 31.8221.82 vs. 35.6716.96 (p< 0.01),
respectively. At 4-months rates of TLF (2.1% vs 4.0%; p¼0.44), TVF (2.1% vs 4.0%;
p¼0.44) and stent thrombosis (0.0% vs 1.0%; p¼0.33) were low and similar in
Ultimaster and Xience arms respectively. The 9-month primary outcome details will
be provided at presentation.
Conclusions: The short term clinical outcomes in bifurcations with the new Ulti-
master DES shows potential. The planned 5-year follow-up of patients will allow more
clear assessment.
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Randomized Comparison Of Provisional Side Branch Stenting Versus A Two-
Stent Strategy For Treatment Of True Coronary Bifurcation Lesions Involving A
Large Side Branch. The Nordic-Baltic Bifurcation Study IV – OCT Substudy
Trine Ørhøj1, Niels R. Holm1, Troels M. Nielsen2, Shengxian Tu3, Michael Maeng4,
Jouke Dijkstra5, Jakob Hjort6, Jens F. Lassen4, Evald H. Christiansen7
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5Leiden University Medical Center, Leiden, The Netherlands, 6Aarhus University
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Background: Optimal treatment of coronary bifurcations with lesions involving a
major side branch (>2.75mm) is unsettled. The randomized Nordic Baltic bifurcation
study IV was ﬁrst to show favorable mid-term results for two-stent techniques
compared to provisional side branch stenting. Two-stent techniques have been asso-
ciated with more stent strut malapposition compared to main vessel only stenting.
Here we present the Nordic Baltic IV OCT substudy.
Methods: Patients included in the Nordic Bifurcation Study IV were offered partic-
ipation in the OCT substudy before randomization. The study stent was Cypher
(Cordis, US) in ﬁrst half of the main study and then Xience (Abbott Vascular, US).
Patients underwent OCT scan post-PCI and at 8 months follow-up. Analysis involved
stent strut malapposition (primary endpoint), strut coverage and ostial side branch
minimal luminal area (MLA) at 8 months follow-up.
Results: A total of 31 patients were included and 27 patients had matched main vessel
follow-up OCT acceptable for analysis. Cypher stent was used in 43 % vs. 31 %
(p¼0.52) in the one-stent vs. two-stent group. Malapposition in the proximal main
vessel after 8 months was 0.12 % vs. 1.10 % (p¼0.10), in the bifurcation segment
towards the side branch 0 % vs. 0.57 % (p¼0.30) and opposite to the side branch; 1.58
% vs. 2.40 % (p¼0.72) for one- and two-stent techniques, respectively. Ostial side
branch MLA was measured using QAngioOCT Cut-plane analysis (Medis Specials,
NL). MLA at baseline was 2.61.2 mm2 in the one-stent group, vs. 4.61.5 mm2
(p¼0.002) in the two-stent group and at 8-month follow-up; 3.33.0mm2 vs. 3.81.5
mm2 (p¼0.64) in the one-stent, vs. two-stent group.
Conclusions: In a randomized comparison of one- and two-stent techniques for
treatment of bifurcation lesions with a large side branch, no signiﬁcant differences in
malapposition were detected. The increased ostial side branch MLA at baseline for
two-stent techniques was not signiﬁcantly different from one-stent techniques at 8-
month follow-up. The OCT ﬁndings support the beneﬁcial mid-term results of two-
stent techniques in bifurcation lesions involving a major side branch.
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Regular Drug-Eluting Stent Versus Dedicated Bifurcation Sirolimus-Eluting
BiOSS LIM Stent In Coronary Bifurcation Treatment – Randomized POLBOS
II Study
Jacek Bil1, Robert J. Gil2, Dobrin Vassilev3, Adam Kern4, Luis A. Iñigo-García5,
Radoslaw Formuszewicz6, Slawomir Dobrzycki7, Leticia Fernandez Lopez5
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Background: Provisional T-stenting (PTS) with regular DES is recommended strat-
egy for coronary bifurcation treatment, however results are not optimal. POLBOS II
study is continuation of POLBOS I study, in which paclitaxel-eluting stent BiOSS
Expert (Balton, Poland) was assessed.
Methods: In POLBOS II study patients with stable CAD or NSTE-ACS were ran-
domized to group where dedicated bifurcation sirolimus-eluting BiOSS LIM stent
was implanted or to group where regular DES was used. The enrollment lasted be-
tween November 2012 and December 2013 in ﬁve centers in Poland and Spain. PTS
was default strategy. An angiographic control was planned at 12 months in all pa-
tients. The primary end-point is MACE after 12 months. Here, we present complete 6-
month clinical follow-up. At the time of TCT 2014 angiographic follow-up will be
almost completed.
Results: There were implanted 104 BiOSS LIM stents and 100 regular DES. Mean
age did not differ signiﬁcantly between groups (BiOSS vs DES: 66.7 vs 65.5 yrs). In
BiOSS group there were signiﬁcantly more patients with hypertension (97.2% vs
87.5%), diabetes (44.4% vs 37.5%) and chronic kidney disease (13.9% vs 9.5%). TheB54 JACC Vol 64/11/Suppl B j Sedominant vessel was LAD (BiOSS vs DES: 46% vs 57%) followed by LMS (37%
vs 18%). According to Medina classiﬁcation true bifurcations were present in 65%.
In DES group 20% of stents eluted sirolimus, 24% - paclitaxel and 45% - ever-
olimus. There were following nominal stent parameters: in BiOSS group
3.730.43 mm (proximal diameter) x 3.030.4 mm (distal diameter) x 17.72.9
mm (length) and in DES group: 3.290.52 mm x 20.16.9 mm. Except for 1 (1%)
case in DES group and 1 (0.9%) in BiOSS group all stents were implanted suc-
cessfully without any serious periprocedural complications. Regular DES in side
branch was implanted in BiOSS group and DES group, in 5.7% and 2% of cases,
respectively. At six months in BiOSS group there were 2 TLR and in DES group -
1 TLR and 1 TVR.
Conclusions: Collected data demonstrate comparable immediate and short-term
clinical results for both groups. Full data enable to answer the question if BiOSS LIM
is comparable to regular DES and if it is superior to BiOSS Expert stent assessed in
POLBOS I study.
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Natural History Of Side-Branch Jailing 5 Years After Implantation Of The
Everolimus-Eluting Bioresorbable Vascular Scaffold. A 3D Optical Coherence
Tomography Assessment
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Background: The observation of tissue bridge growth after bioresorbable scaffold
(BVS) implantation, together with the high strut thickness raises questions about the
long-term patency of side-branches jailed by BVS. We investigated by optical
coherence tomography (OCT), the fate of side-branches jailed by elective BVS im-
plantation at a 5-years follow-up.
Methods: 8/14 living patients enrolled in the Thoraxcenter cohort of ABSORB A,
underwent additional OCT follow-up 5 years post BVS implantation. Side-branches
jailed by BVS were identiﬁed. For assessing side-branch jailing over time, three-
dimensional images of side-branch ostia were obtained by dedicated rendering
software. No struts were identiﬁable in OCT pullbacks, but neointimal bridges had
developed in their place. Neointimal bridges were classiﬁed based on their relative
location to the ostium as proximal, distal, proximal and distal, or crossing. Mean and
minimal thickness was measured in matched frames at 2- and 5-year follow-up using
QCU-CMS. Side-branch ostium area assessment was performed using dedicated
software. Following three-dimensional reconstruction, a cut-plane perpendicular to
the side-branch centerline was selected and side-branch ostium planimetry was
performed.
Results: All side branches were patent with TIMI III ﬂow. Overall, 14 side-branches
were associated with incompletely apposed struts at previous examinations. Neo-
intimal bridges at 5 years were identiﬁed in 13 side-branches, whereas in one no
bridge was visible (Table). Minimal and mean thickness of neointimal bridges over-
lying side-branches were respectively reduced from 24192mm and 341106mm at 2
years to 161107mm and 227119 at 5 years (p< 0.01)Conclusions: At long-term after BVS implantation, jailed side-branch ostia are
preserved, while side-branch related struts have been replaced by thin tissue
bridges.ptember 13–17, 2014 j TCT Abstracts/Coronary Lesions - Bifurcations
